Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SeQuent Scientific Limited

http://www.sequent.in

Latest From SeQuent Scientific Limited

2021 Deal Action In India: Watch Private Equity And E-Pharmacy

Most roads led to India in 2020 when it came to deals to expand access to COVID-19 therapies, but the challenging year also saw significant private equity interest and there are expectations of more action ahead in the new year.

Deals M & A

Hetero Launches India's First Generic Of Gilead’s Biktarvy

Hetero launches cut-price version of Gilead’s Biktarvy in India but 20 other India-based firms also hold licenses for the product. Gilead is entitled to a “modest royalty” on products produced under the voluntary license.

Launches Strategy

First Generic Of Gilead’s Biktarvy In India Debuts

Hetero launches cut-price version of Gilead’s Biktarvy in India but 20 other India-based firms also hold licenses for the product. Gilead is entitled to a “modest royalty” on products produced under the voluntary license.

Commercial Strategy

Strides, Shasun Pair To Rebuild Fortunes Via Mutual Strengths

Strides and Shasun have seen an opportunity to grow as a single combined unit. The match is a no-brainer – Strides needs scale to make a global splash after selling Agila last year, while Shasun requires management bandwidth to pull it out of sagging prospects in APIs and CRAMS.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Diversified
  • Pharmaceuticals
UsernamePublicRestriction

Register